BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Calendar//CN-US Event Research//ZH
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Calendar
X-WR-CALDESC:Market-moving event research, reminders and post-event review.
BEGIN:VEVENT
UID:evt-nhsa-2026-nrdl-commercial-innovative-drug-catalog-application@catalyst-calendar.local
DTSTAMP:20260601T102650Z
DTSTART:20260601T010000Z
DTEND:20260601T013000Z
SUMMARY:2026年国家医保目录及商保创新药目录调整申报窗口开启
DESCRIPTION:国家医保局发布2026年医保药品目录及商业健康保险创新药品目录调整相关文件，并明确2026年6月1日至6月10日开通网上申报系统。本次调整涉及创新药、续约、竞价和商保创新药目录衔接，对A/H创新药、仿制药和中成药板块具备行业级定价影响。\\nImpact score: 83\\nExpected: 申报名单、资格审核和后续谈判预期会影响创新药销售峰值、支付可及性和续约降价预期。\\nAffected: 600276.SH(theme\, mixed\, score 78)\; 9926.HK(theme\, mixed\, score 80)\; 1801.HK(theme\, mixed\, score 78)\; 6990.HK(theme\, mixed\, score 72)\; 1177.HK(theme\, mixed\, score 70)\; 512170.SH(etf\, mixed\, score 66)\\nSources: 国家医保局正式文件发布: https://www.nhsa.gov.cn/art/2026/5/31/art_109_20816.html\\n国家医保局方案解读实录: https://www.nhsa.gov.cn/art/2026/5/26/art_14_20707.html\\nInformation only. Not investment advice.
URL:https://0.0.0.0:3000/?event=evt-nhsa-2026-nrdl-commercial-innovative-drug-catalog-application
CATEGORIES:policy\,CN\,医保目录\,创新药\,商保创新药目录\,药品支付
SEQUENCE:0
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:Review catalyst preview: 2026年国家医保目录及商保创新药目录调整申报窗口开启
END:VALARM
BEGIN:VALARM
TRIGGER:PT24H
ACTION:DISPLAY
DESCRIPTION:Complete post-event review: 2026年国家医保目录及商保创新药目录调整申报窗口开启
END:VALARM
END:VEVENT
END:VCALENDAR